Topchoice Medical Co Inc
SSE:600763
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telephone and Data Systems Inc
NYSE:TDS
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (32.9), the stock would be worth ¥51.68 (21% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 27.2 | ¥42.65 |
0%
|
| 3-Year Average | 32.9 | ¥51.68 |
+21%
|
| 5-Year Average | 42.8 | ¥67.24 |
+58%
|
| Industry Average | 26.2 | ¥41.13 |
-4%
|
| Country Average | 28.8 | ¥45.24 |
+6%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥18.3B
|
/ |
Apr 2026
¥705.3m
|
= |
|
|
¥18.3B
|
/ |
Dec 2026
¥1.1B
|
= |
|
|
¥18.3B
|
/ |
Dec 2027
¥1.2B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Topchoice Medical Co Inc
SSE:600763
|
19.1B CNY | 27.2 | 37.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14.2 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 7.9 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 9.1 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 9.2 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 11.7 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 11.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 5.3 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -30.5 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 7.2 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.3 |
| Median | 28.8 |
| 70th Percentile | 53.1 |
| Max | 49 021 |
Other Multiples
Topchoice Medical Co Inc
Glance View
Topchoice Medical Co Inc., founded in 1996 in China, stands as a notable entity in the burgeoning healthcare sector, particularly in the realm of medical services. The company operates a network of dental hospitals and clinics, making it a pivot in the community for people seeking dental and medical care services. With a business model grounded in patient-centered care and technological integration, Topchoice Medical efficiently blends traditional medical practices with modern innovations. This approach allows it to cater to a wide spectrum of health needs, from routine dental check-ups and orthodontic treatments to more advanced surgical procedures. Their emphasis on quality and professional expertise has cemented their reputation, fostering a loyal customer base that trusts the brand for its medical and dental needs. Revenue generation at Topchoice stems from its multi-faceted healthcare services that are packaged with both preventative and acute care solutions. By operating across diverse geographical locations and acquiring smaller clinics, the company ensures a steady influx of patients, thereby securing consistent revenue streams. Additionally, strategic partnerships and collaborations with medical equipment manufacturers and pharmaceutical companies bolster their service offerings and operational efficiency. The company's ability to leverage technology, such as digital health records and telemedicine, enhances its service delivery, ensuring customer satisfaction and operational scalability. As a result, Topchoice Medical not only thrives on patient care but also capitalizes on innovations and strategic expansions to sustain its financial growth and market positioning.
